# Balanites aegyptiaca **Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/balanites-aegyptiaca **Data Source:** Hermetica Superfoods Ingredient Encyclopedia **Updated:** 2026-03-27 **Evidence Score:** 6 / 10 **Category:** African **Also Known As:** Desert date, Ingudi, Egyptian balsam, Soap berry tree, Zachum oil tree, Thorn tree, Heglig, Lalob, Bedena ## Overview Balanites aegyptiaca is a desert tree whose fruits contain saponins and flavonoids that help regulate blood glucose levels. The plant's bioactive compounds work by enhancing pancreatic function and improving [insulin sensitivity](/ingredients/condition/weight-management). ## Health Benefits • Blood sugar regulation: Reduced 2-hour postprandial glucose by 26.88% in type 2 diabetes patients (pilot RCT) • Fasting glucose reduction: Decreased fasting plasma glucose by 10.3% over 8 weeks (limited evidence from one small trial) • Pancreatic protection: Preclinical studies suggest protection of pancreatic β-cells through reduced IL-1β and iNOS expression (animal studies only) • [Antimicrobial](/ingredients/condition/immune-support) activity: Demonstrated effects against bacteria with MIC of 62.5 µg/mL (in vitro evidence only) • Traditional diabetes management: Historical use across African medicine systems for hyperglycemia (traditional evidence) ## Mechanism of Action Balanites aegyptiaca's saponins and flavonoids appear to enhance pancreatic beta-cell function and improve peripheral [insulin sensitivity](/ingredients/condition/weight-management). The compounds may also inhibit glucose absorption in the intestines through alpha-glucosidase enzyme inhibition. Additionally, the plant's [antioxidant](/ingredients/condition/antioxidant) properties help protect pancreatic cells from oxidative damage. ## Clinical Summary One pilot randomized controlled trial in type 2 diabetes patients showed 26.88% reduction in 2-hour postprandial glucose levels. A small 8-week trial demonstrated 10.3% decrease in fasting plasma glucose, though sample size was limited. Most evidence comes from preclinical studies suggesting pancreatic protective effects. Human clinical data remains sparse and requires larger, longer-duration trials for validation. ## Nutritional Profile Balanites aegyptiaca (desert date) fruit, seed, and leaf fractions contain distinct nutritional compositions. Fruit pulp: carbohydrates 40–60% dry weight (primarily sugars and dietary fiber), crude protein 5–8%, crude fat 1–3%, ash 3–5%. Seed kernel: crude fat 40–55% (rich in oleic acid ~30% and linoleic acid ~15% of fatty acid profile), crude protein 25–30%, with amino acids including lysine and methionine. Bioactive compounds: steroidal saponins (diosgenin glycosides, balanitin 1–7) at approximately 1–3% dry weight of seed — these are considered primary pharmacologically active constituents linked to glucose regulation; furostanol saponins identified as major blood sugar-modulating agents. Phenolic compounds: flavonoids (quercetin, kaempferol derivatives) and phenolic acids (gallic, ferulic acid) estimated at 15–40 mg GAE/g in methanolic extracts. Minerals: calcium (~300–500 mg/100g dry pulp), iron (~5–10 mg/100g), zinc, potassium, and phosphorus present at nutritionally relevant levels. Vitamins: ascorbic acid (vitamin C) reported at 30–80 mg/100g fresh pulp; beta-carotene precursors detected. Fiber: total dietary fiber 10–20% dry weight in pulp, supporting glycemic modulation. Bioavailability note: saponin bioavailability may be limited by gut hydrolysis to aglycone diosgenin; fat-soluble compounds in seed oil show improved absorption with dietary fat co-ingestion. Tannin content (~2–4%) may reduce mineral and protein bioavailability if consumed in large quantities. ## Dosage & Preparation Clinically studied dosage: 400 mg/day of 70% ethanol pericarp extract in capsule form for 8 weeks. No other human-studied dosages or forms have been established. Consult a healthcare provider before starting any new supplement. ## Safety & Drug Interactions Limited safety data exists for Balanites aegyptiaca supplementation in humans. The plant may interact with diabetes medications by enhancing their glucose-lowering effects, potentially causing hypoglycemia. Pregnant and breastfeeding women should avoid use due to insufficient safety data. Individuals with diabetes should monitor [blood glucose](/ingredients/condition/weight-management) closely and consult healthcare providers before use. ## Scientific Research A single randomized, double-blind, placebo-controlled pilot trial (n=30 type 2 diabetes patients) tested 400 mg/day of 70% ethanol pericarp extract for 8 weeks, showing significant reductions in postprandial and fasting glucose. A 2024 systematic review of 32 preclinical studies confirmed antidiabetic effects in animal models but emphasized the need for full-phase human trials. No PMIDs were provided in the research dossier. ## Historical & Cultural Context Balanites aegyptiaca has been used in traditional African medicine systems across Egypt, Nigeria, Ethiopia, and Saudi Arabia for managing diabetes and hyperglycemia. The ethnomedicinal use of various plant parts for diverse ailments predates modern scientific investigation, with roots in xerophytic regional practices. ## Synergistic Combinations Cinnamon extract, Chromium picolinate, Alpha-lipoic acid, Bitter melon, Gymnema sylvestre ## Frequently Asked Questions ### How much does Balanites aegyptiaca lower blood sugar? Clinical studies show Balanites aegyptiaca reduced 2-hour post-meal glucose by 26.88% and fasting glucose by 10.3% over 8 weeks. However, these results come from small preliminary trials and need confirmation in larger studies. ### What part of Balanites aegyptiaca is used medicinally? The fruits and bark of Balanites aegyptiaca are traditionally used for medicinal purposes. The fruits contain the highest concentration of active saponins and flavonoids responsible for blood sugar regulation effects. ### Can Balanites aegyptiaca replace diabetes medication? No, Balanites aegyptiaca cannot replace prescribed diabetes medications. While preliminary studies show glucose-lowering effects, the evidence is too limited to recommend as a standalone treatment for diabetes management. ### What is the recommended dosage of Balanites aegyptiaca? No standardized dosage exists for Balanites aegyptiaca supplements due to limited clinical research. Traditional preparations vary widely, and more studies are needed to establish safe and effective dosing guidelines. ### Are there side effects from taking Balanites aegyptiaca? Side effects of Balanites aegyptiaca are not well-documented in clinical literature. Potential risks include hypoglycemia when combined with diabetes medications and unknown interactions due to limited safety research in humans. ### Does Balanites aegyptiaca interact with diabetes medications like metformin or insulin? Balanites aegyptiaca has demonstrated blood sugar-lowering effects in clinical studies, which raises the potential for additive effects when combined with prescription diabetes medications. Co-use with metformin, insulin, or sulfonylureas may increase hypoglycemia risk and requires medical supervision and possible dose adjustment. No formal drug interaction studies have been conducted, so consult your healthcare provider before combining with diabetes medications. ### Is Balanites aegyptiaca safe to use during pregnancy or while breastfeeding? Safety data for Balanites aegyptiaca during pregnancy and lactation is insufficient; no controlled human studies exist in these populations. Given its pharmacological activity on blood glucose regulation, use during pregnancy should be avoided without explicit medical clearance. Women who are pregnant or breastfeeding should consult a healthcare provider before considering this supplement. ### What does the current research evidence show about Balanites aegyptiaca's effectiveness for blood sugar control? Available clinical evidence is limited to a single small pilot randomized controlled trial showing a 26.88% reduction in postprandial glucose and 10.3% reduction in fasting glucose in type 2 diabetes patients. Mechanistic animal studies suggest pancreatic β-cell protection, but these findings have not been confirmed in human trials. More robust, large-scale human clinical trials are needed before strong conclusions about efficacy can be drawn. --- *Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com* *License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*